Substance Use Prevention

According to the Centers for Disease Control and Prevention, nearly 48,000 people in the U.S. died from an opioid overdose in 2017, the highest number ever recorded. People dependent on prescription opioids are 40 times more likely to become dependent on heroin. Prescription opioid misuse, overdose, and dependence also takes a financial toll, accounting for more than $78 billion a year in health care, criminal justice, and lost productivity costs. Yet insurers—particularly Medicare and Medicaid—have limited options for curtailing the misuse of these drugs, and prescribers need better tools to detect which patients may be at risk of harm.

Pew develops and supports policies to reduce the inappropriate use of prescription drugs while ensuring that patients have access to effective pain management. 

Additional Resources

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.